Rossari Biotech's IPO Set To Open On Monday. Here's All You Need To Know

Rossari Biotech's initial public offer (IPO) will open for subscription for three trading days starting Monday, July 13. Trading in the Rossari IPO will be available from 10:00 am to 5:00 pm. Mumbai-based specialty chemicals maker Rossari Biotech said on Friday it had raised Rs 149 crore from anchor investors, including Abu Dhabi Investment Authority, HDFC Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HDFC Life Insurance Company and Goldman Sachs India.

Here are 10 things to know about the Rossari Biotech IPO:

1. Mumbai-based Rossari Biotech is a specialty chemicals manufacturer which has diversified into animal health and nutrition, home, personal care and performance chemicals markets

2. Rossari Biotech - which filed its draft papers with market regulator Sebi in December last year, received a go-ahead for the IPO in February. Rossari Biotech shares will be listed on the NSE and BSE.

3. Rossari Biotech's public offer comes after four months of inactivity in the country's IPO market. SBI Cards & Payment Services was the last company to float IPO in March.

4. Rossari's up to Rs 496-crore public offer includes a fresh issue of Rs 50-crore shares and an offer of sale of 1.05 crore shares.

5. An issue price of Rs 423-Rs 425 has been set for the IPO. At the upper end of the price band, the offer for sale is estimated at Rs 446.25 crore. 

6. Rossari Biotech shares will be available in lots of 35 shares in the IPO. In other words, investors will be able to apply for Rossari shares for a minimum of Rs 14,805-14,875 in multiples of 35 shares.

7. While half of the Rossari Biotech IPO is reserved for qualified institutional buyers (QIBs), 15 per cent is reserved for non-institutional investors, and the remaining 35 per cent for retail investors. Retail investors are permitted a maximum subscription amount of Rs 2,00,000 under the Rossari Biotech IPO. 

8. Net proceeds from the issue will be utilised for funding working capital requirements, repayment/prepayment of certain loans and for general corporate purposes.

9. Book running lead managers for the Rossari Biotech IPO are Axis Capital and ICICI Securities.

10. Rossari Biotech provides customised solutions to cater to the industrial and production requirements of its customers through a diversified product portfolio, according to its website.